“The number one challenge in immunotherapy development is getting the right patients onto the right clinical trials,” said Ronald A. DePinho, a leading cancer researcher and co-founder of Bectas ...

Image : F. Duval, UNIGE. Immune hubs within tumors can either strengthen the body’s antitumor response or silently dampen it. These structures form in close proximity to blood vessels (pink, ...

The interplay between inflammation and immune suppression is central to host defense during infectious diseases. An appropriate inflammatory response is ...

Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified a strategy to maximize the effectiveness of anti-cancer immune therapy. The researchers ...

Pilatus Biosciences Announces FDA Clearance of IND Application for PLT012, a First-in-Class Anti-CD36 Metabolic Checkpoint ...